MUC16 and ovarian serous adenocarcinoma: Sensitivities at a fixed specificity of 100 and 99.6%, specificities at fixed sensitivity of 75% and area under the curve (AUC) of JUP, CA125 and the combination of both markers for stage I–III serous ovarian cancer.